4.7 Article

Comparative study between chemical coagulation/precipitation (C/P) versus coagulation/dissolved air flotation (C/DAF) for pre-treatment of personal care products (PCPs) wastewater

Journal

DESALINATION
Volume 252, Issue 1-3, Pages 106-112

Publisher

ELSEVIER
DOI: 10.1016/j.desal.2009.10.016

Keywords

Industrial wastewater; Coagulation; DAF; COD; Oil and grease; Sludge

Ask authors/readers for more resources

For pretreatment of wastewater discharged from personnel care products (PCPs) factory, two treatment schemes were investigated. The 1st step in both schemes was chemical coagulation followed by precipitation in the 1st scheme and dissolved air flotation in the 2nd one. Ferric chloride (FeCl3 center dot 6H(2)O), alum (Al-2 (SO4)(3)center dot 18H(2)O) and ferrous sulfate (FeSO4 center dot 6H(2)O) were used as coagulants. Lime (CaO) was used as coagulant aid and for pH adjustment. For C/P, the three coagulants investigated were found to be more or less similar in their performance. Maximum CODtotal removal obtained by ferric chloride, ferrous sulfate and alum was 75.8 +/- 9.7, 77.5 +/- 9.6 and 76.7 +/- 9.9%, respectively. Corresponding BOD5 (total) removal values were 78 +/- 15.8. 78.7 +/- 15.6 and 74.1 +/- 19.3%, respectively. However. the optimum dose of ferric chloride and alum was 600 and 700 mg/l while that of ferrous sulfate was 850 mg/l. Alum produced a voluminous sludge. but with the least solids content. Ferric chloride produced compact sludge with a good settleability as reflected by the low sludge volume index (SVI) of 76.3 +/- 28.8 ml/gTSS. In the coagulation-dissolved air flotation (C/DAF) experiments, the results showed that alum produced higher COD removal (77.5 +/- 3.2%) as compared to ferric chloride (71.6 +/- 2.9%) and ferrous sulfate (67.7 +/- 3.7%). A cost evaluation of the initial investment and the running costs using the different coagulants at their optimum operating conditions were calculated. The investment and running cost for C/P process is higher by 27.3 and 23.7% than C/DAF. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available